Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis - Reiberger, T; Ferlitsch, A; Payer, B A; Vienna Hepatic Hemodynamic Lab (J Hepatol, 2013)